Tag Archives: specialty pharmacies

Distribution

Limited Distribution Networks

Posted on by John Santilli

Limited Distribution Networks growth continues as Specialty Pharmacies compete to be chosen to distribute specialty pharmaceuticals. AMI’s report, Distribution Decision-Making for Specialty Drugs, found that Pharmaceutical manufacturers typically develop a product-specific distribution strategy dependent on company-specific criteria when bringing a new specialty drug to the market. Pharmaceutical manufacturers consider approximately 100-150 different specialty pharmacies (SPs) […]

Continue reading →
Market Intelligence

Why CVS Recent Deals Change the Specialty Landscape

Posted on by John Santilli

Why CVS Recent Deals Change the Specialty Landscape – Following a similar path as in the late 1990’s with long term care pharmacy, specialty pharmacy has matured enough to undergo consolidation and roll-up into larger healthcare entities. Specialty represents a small distribution volume in the retail pharmacy space but also results in the greatest profit […]

Continue reading →
Dr. Randy Vogenberg

Seeking Value: Managing Specialty Medications and Medication Adherence

Posted on by John Santilli

Amid the constant change churning the health care marketplace, employers have the opportunity to use value-based tactics to get more for their health benefits, including pharmaceutical spending that is currently the biggest driver of rising health care costs. That message was echoed by all four speakers at the Alliance Learning Circle on “Doses and Dollars: […]

Continue reading →
Market Intelligence

Contracting With Specialty Pharmacies (SPs) At Your Own Peril

Posted on by Dr. Randy

How a company works with and contracts with SPs will have to be rethought as a result of the initial Department of Justice (DoJ) settlement with BioScrip and ongoing investigation of Novartis in their marketing practices. When Novartis launched Exjade, it created a limited distribution network, including BioScrip and two other specialty pharmacies selected by […]

Continue reading →
Market Intelligence

Walgreens Specialty Pharmacy Exclusive Distributor for Three Sigma-Tau Drugs

Posted on by AMI
01
Aug

The deal includes Sigma-Tau’s Adagen (pegademase bovine), Cystaran (cysteamine ophthalmic solution), and Matulane (procarbazine hydrochloride). As a result of the agreement, each of these prescription drugs can now be obtained through Walgreens Specialty Pharmacy locations. Adagen is an intramuscular injection indicated for replacement therapy for adenosine deaminase (ADA) deficiency in patients with severe combined immunodeficiency […]

Continue reading →
Market Report

Hepatitis C and Specialty Pharmacy Market

Posted on by aprilgregory

Express Scripts Plans a Specialty Drug Price War over new hepatitis C treatments reports a recent Bloomberg News story. The news follows the release of Gilead’s Sovaldi (sofosbuvir), which reportedly costs $1,000 per pill. Express Scripts projects that Hepatitis C drug trend will grow by 168% by 2015, so employers and health plan payers are […]

Continue reading →
Market Report

Contracting With Specialty Pharmacies (SPs) At Your Own Peril

Posted on by aprilgregory

How a company works with and contracts with SPs will have to be rethought as a result of the initial Department of Justice (DoJ) settlement with BioScrip and ongoing investigation of Novartis in their marketing practices. When Novartis launched Exjade, it created a limited distribution network, including BioScrip and two other specialty pharmacies selected by […]

Continue reading →